(Telecompaper) European broadcaster RTL has trimmed its outlook for full-year results due to weakness in the German advertising market. RTL posted revenues for the first nine months of the year down 1.5 percent on an organic basis to EUR 4.2 billion and lowered its FY outlook to EUR 6.3 billion in sales, from a...

(Telecompaper) MultiChoice Group says that revenue increased by 4 percent year on year to ZAR 25.4 billion on an organic basis in the six months to September thanks to disciplined inflationary pricing and revenue growth for new products. On a reported basis, revenues declined by 10 percent, hit by foreign...

The Chinese electric vehicle giant BYD has seen its quarterly revenues soar, beating Tesla’s for the first time. It posted more than 200bn yuan ($28.2bn, £21.8bn) in revenues between July […]

The post BYD revenues overtake Tesla’s, Reddit makes profit for first time appeared first on ShinyShiny.

The house doesn't always win.

There has been a decided push in both technology and interest — from both security integrators and customers — on the cloud-based services that bring recurring monthly revenue.

The new availability of rXg will greatly reduce the time and labor required to implement multi-tenant networks including those offering paid or tiered services.

Visual Components, developer of 3D simulation software, surveyed more than 300 manufacturing decision-makers in the U.S., UK and Germany.

The post Principles for the 2025 Tax Debate: End High-Income Tax Cuts, Raise Revenues to Finance Any Extensions or New Investments was curated by information for practice.

The accession of new territories to Russia is justifiable from the economic point of view and will not have a negative impact on the Russian budget, the Kremlin said. As Russia readies to grow even larger, experts try to calculate how much it will cost the Russian budget to rebuild cities and restore peaceful life in the new territories. Some others try to find out how much profit the new territories will bring. The Washington Post announced the approximate cost of mineral deposits in the new regions — about 12.4 trillion dollars.

Following a record year in 2022, real-time data capture, printing, mobility and voice-directed solutions specialist, Dakota Integrated Solutions, has again exceeded projected revenue and growth targets during 2023.

Source: Streetwise Reports 11/08/2024

Vertex Pharmaceuticals Inc. (VRTX:NASDAQ) has reported a robust financial performance for the third quarter of 2024. The report has demonstrated the company's continued revenue growth and the strengthening of its innovative pipeline. For Q3 2024, Vertex's product revenue reached US$2.77 billion, a 12% increase from the previous year. This was primarily driven by strong demand for its TRIKAFTA®/KAFTRIO® therapies. Based on this momentum, Vertex raised its full-year product revenue guidance to a range of US$10.8 billion to US$10.9 billion, citing a solid trajectory in its cystic fibrosis (CF) portfolio and expected future launches.

In Q3, the company made notable advancements in its pipeline. Three programs have begun moving into Phase 3 clinical development: suzetrigine in diabetic peripheral neuropathy (DPN), povetacicept in IgA nephropathy (IgAN), and VX-880 in type 1 diabetes (T1D). Vertex is also preparing for the launch of two potential treatments in early 2025, with PDUFA dates set for January 2 for the vanzacaftor triple therapy for CF and January 30 for suzetrigine, the latter being a pain medication in a new therapeutic class aimed at reducing reliance on opioids.

GAAP and Non-GAAP net income both reached US$1.0 billion, largely driven by increased product revenue, which offset rising R&D and SG&A expense. This was s due to investments in global commercialization and late-stage clinical development. For Q3, Vertex's combined R&D and SG&A expenses were US$1.2 billion and US$1.1 billion, respectively, an increase from last year attributed to new global program advancements and upcoming launch support.

Vertex's cash position remained strong, with US$11.2 billion in cash, cash equivalents, and marketable securities as of September 30. The decline from US$13.7 billion at the end of 2023 primarily reflects the acquisition of Alpine Immune Sciences and share repurchases under the company's buyback program.

A Look At Biotechnology and Pharma

The U.S. Pharmaceuticals Report for 2024 by Nova One Advisor detailed the size and growth trajectory of the U.S. pharmaceutical market. Valued at US$602.19 billion in 2023, the sector is projected to exceed US$1 trillion by 2033. The report pointed to a "high healthcare expenditure provided by government bodies" as a primary growth driver, further bolstered by the aging population's demand for advanced treatments.

In an October 24 article, The Investing News Network reported on a dynamic landscape within the biotechnology sector. The report highlighted advancements in AI-powered drug discovery. Despite a cautious investment climate, interest remained strong in AI's potential to reshape healthcare, with venture capital investment reaching US$6.59 billion. At the HealthTech Ignite conference, Susie Roberts from Relay Therapeutics expressed confidence, noting, "We will definitely see AI design drugs in the next 10 years."

On November 4, Yahoo! Finance shared insights from MIT professors Andrew Lo and Dennis Whyte. They emphasized that biotechnology's rapid advancement over the past five decades offers valuable lessons for future innovation. In their research paper, Lo and Whyte proposed initiatives to accelerate biotechnology's growth, underscoring the importance of "reducing risk and uncertainty" to foster a robust investment ecosystem that supports groundbreaking discoveries.

Catalysts Driving Vertex Pharma

According to Vertex's November 2024 investor presentation, the company sees multiple growth catalysts over the next few years. Vertex aims to meet its goal of achieving "five launches in five years," focusing on expanding the treatable patient base in CF with vanzacaftor triple, addressing critical needs in sickle cell disease (SCD) and beta thalassemia (TDT) with CASGEVY, and launching suzetrigine for acute pain management.

Additionally, Vertex expects its expansive R&D pipeline to support long-term growth. This includes pivotal clinical trials for VX-880 in T1D, povetacicept in IgAN, and NaV1.8 pain inhibitors like suzetrigine, indicating a commitment to treating a range of chronic and life-threatening conditions with limited therapeutic options.

By driving advancements in CF therapies, diversifying its portfolio with novel pain treatments, and pursuing accelerated approvals for renal and blood-related disorders, Vertex is strategically positioning itself to sustain growth and achieve several near-term milestones.

What Are Experts Saying About Vertex?

In a November 5, 2024, H.C. Wainwright & Co. update, the analysts highlighted promising data from Vertex's recent Phase 2 trial for suzetrigine, which showed encouraging reductions in pain intensity. [OWNERSHIP_CHART-4085]

The analysts noted that suzetrigine's peripheral nervous system-specific mechanism could potentially address "a significant, unmet medical need worldwide" in non-opioid pain management. They set a price target of US$600.00, projecting Vertex's continued growth from its strong cystic fibrosis franchise and pipeline expansion.

From the November 7 Kingswood Capital Partners report, analysts noted Vertex Pharmaceuticals' "sustained execution" in advancing product development programs and achieving robust operating margins, enabling "continued, significant investments" in both its pipeline and commercial capabilities. The firm maintained a "Buy" rating with a 12-month target price of US$550.00, attributing this outlook to Vertex's deep cash resources and historical successes in clinical trials.

Ownership and Share Structure

According to Refinitiv, 95.44% of Vertex Pharmaceuticals is held by Institutions. The top among them are Capital World Investors at 10.37%, The Vanguard Group at 8.88%, BlackRock Institutional Trust with 5.49%, State Street Global Advisors (US) with 4.55%, and Fidelity Management and Research with 4.11%. Strategic Investors hold .12%. The rest is retail.

The company's market cap is US$129,395.59 million with 257.07 million free float shares. The 52 week range is US$341.90–$510.64.

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Important Disclosures:

1) James Guttman wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.

2) This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

For additional disclosures, please click here.

( Companies Mentioned: VRTX:NASDAQ, )

Silver Crown Royalties Inc. (SCRI:CBOE; SLCRF:OTCQX; QS0:FSE) announced record quarterly revenues in its financial results for the third quarter ending on September 30, 2024. Read more about the impressive growth in silver deliveries and how the company is strategically positioned for continued expansion.

Global fisheries stand to lose approximately $10 billion of their annual revenue by 2050 if climate change continues unchecked, and countries that are most dependent on fisheries for food will be the hardest hit, finds new UBC research.

read more

“This is definitely a tipping point. We are going from about 1 gigawatt of data center capacity to about 3 gigawatt as a country. And we are all set for that - whether it is within data center or inter-data center connectivity, from laying the fibre from the landing station into the data centers, all of that is something we are very well set to do.”

The most expensive part of plumbing service is getting the phone to ring and the truck to the job. Once there, every additional dollar past breakeven helps cover the monthly overhead nut. Once this is covered, it falls straight to the bottom line. So, how can you maximize revenue? Here are nine ways to boost your average tickets.

Global safety equipment manufacturer MSA Safety Incorporated reported results for the fourth quarter and full year of 2017.

Mike Bazar Appointed To Chief Revenue Officer

Burlywood is committed to transforming the SSD industry from a hardware-centric, one-size-fits-all market to software-defined flash solutions that optimize the needs of individual applications.

HITEKS™ Insight: The Only Note Editor Embedded Within Epic Workflows That Helps Providers Comply With Quality Diagnoses & Fair Reimbursement

n-tech projects that smart antibacterial and antiviral products will reach US$1.3 billion by 2025 driven by efforts to combat Covid-19 and provide safer workplace, health care and improved public health

New listener demographics released by CMA highlight online and mobile opportunities

A unique business to business event connecting you with the hottest Korean F&B innovations.

Inga Ellzey Shares Preparation Tips to Ensure Dermatology Practice Fiscal Health

CareWork Inc. a premier SaaS provider in the senior living and long-term care sector that improves operational efficiency through standardized analytics, achieved significant revenue growth over 500% in the first seven months of 2024

Branded apparel and promotional products franchise closes out banner year under new leadership.

The world-first, skills-matching technology platform eradicates traditional barriers for job seekers by uberising the job market globally.

Practical strategies are needed to bring the businesses back, one small business at a time.

AspireSix and RevOps Global announce strategic partnership to elevate revenue operations for high-growth companies

Pangyo Technovalley 1 and 2 will connect with each other to provide a better environment for resident companies. We will continue support to develop Pangyo Technovalley the center of Korean and global techno valley.

Capri Holdings has reported Q2 FY25 revenue of $1.08 billion, a 16.4 per cent YoY decline. Gross profit reached $694 million with a margin of 64.3 per cent. Versace, Jimmy Choo, and Michael Kors saw mixed results, with sales declines for Versace and Kors but slight growth for Jimmy Choo. Net income was $24 million, down from $90 million YoY.

Wolverine World Wide has reported Q3 revenue of $440.2 million, down 16.6 per cent YoY, with gross margin up 450 basis points to 45.3 per cent. Net debt fell to $563 million. For FY2024, the company projects revenue of $1.730-$1.745 billion, with a gross margin of 44.5 per cent and adjusted EPS between $0.80 and $0.90. Inventory is expected to decline by $85 million.

Wolverine World Wide has reported Q3 revenue of $440.2 million, down 16.6 per cent YoY, with gross margin up 450 basis points to 45.3 per cent. Net debt fell to $563 million. For FY2024, the company projects revenue of $1.730-$1.745 billion, with a gross margin of 44.5 per cent and adjusted EPS between $0.80 and $0.90. Inventory is expected to decline by $85 million.

Page Industries Limited has reported revenue of ₹12,463 million (~$147.7 million) in Q2 FY24, a YoY increase of 11 per cent, with sales volume rising 6.7 per cent to 55.2 million pieces. EBITDA grew 22 per cent YoY to ₹2,815 million (~$33.4 million), with a margin of 22.6 per cent. PAT was ₹1,953 million, up 29.9 per cent. For H1 FY24, revenue was ₹25,238 million, growing 7.3 per cent YoY.

Page Industries Limited has reported revenue of ₹12,463 million (~$147.7 million) in Q2 FY24, a YoY increase of 11 per cent, with sales volume rising 6.7 per cent to 55.2 million pieces. EBITDA grew 22 per cent YoY to ₹2,815 million (~$33.4 million), with a margin of 22.6 per cent. PAT was ₹1,953 million, up 29.9 per cent. For H1 FY24, revenue was ₹25,238 million, growing 7.3 per cent YoY.

Partnership to drive growth in financial services, insurance, and healthcare through AI-enhanced solutions

The Conga Advantage Platform runs in any infrastructure, delivering revenue advantage to every global enterprise at scale

Why $5 million in revenue didn't mean success. Redefine what winning means in the startup world.

The post Redefining Success: I Made $5 Million in Revenue and Still “Failed” first appeared on Chase Jarvis.

The post Redefining Success: I Made $5 Million in Revenue and Still “Failed” appeared first on Chase Jarvis.

How did Top Life Project exceed revenue goals by 59%? The story behind their WooCommerce-powered health brand & booming product launches.

Launching a new B2B software product requires a different approach than traditional go-to-market strategies. The business model you choose should align with varying types of products and market conditions, as it significantly influences overall sales success and the structuring of sales teams. The software space is crowded, and your potential customers are likely already using […]

The post From Research to Revenue: A Complete Guide to B2B Software GTM appeared first on 3.7 Designs.

Although ductwork doesn’t require quite as much maintenance as other HVAC equipment does, there are steps to be taken to ensure its longevity, safety, and efficient operation.

The annual sales growth for the 12 months through September 2024 is an increase of 2.3%. 

The pharmaceutical industry is undergoing a tremendous packaging revolution, paving way for the future development of intelligent solutions. One such breakthrough achieved in this space is the blister packaging.

Apple set revenue records in its fourth-quarter fiscal results, thanks to strong numbers from the iPhone and Services segments and increases from the iPad and Mac. On the downside, revenue growth dropped in the Wearables category, and sales in the Greater China region declined slightly.

Rackspace Technology Reports Decreased Q3 2024 Revenue  TipRanks

Spotify Technology SA (SPOT) Q3 2024 Earnings Call Highlights: Record Growth in Users and Revenue  Yahoo Finance

The tech giant plans to spend big on AI because it sees 'strong momentum' in this area.

Read more: Meta to increase AI spend as revenue soars

Scott Stiglich, senior vice president of channel partnerships at Watercress Financial, breaks down why roofing contractors need to incorporate financing solutions to their business model in this exclusive Q&A.